Cite
HARVARD Citation
Reinisch, W. et al. (n.d.). P658 Comparative Efficacy and Safety of Upadacitinib Versus Tofacitinib as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: A Matching-Adjusted Indirect Comparison. Journal of Crohn's and colitis. pp. i785-i786. [Online].